St Luke's Home Care / Hospice 325 West Idaho St, Boise, ID, 83702 | |
(208) 381-2721 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.
According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
› Verified 6 days ago
Name | St Luke's Home Care / Hospice |
---|---|
Location | 325 West Idaho St, Boise, Idaho |
Hospice ID | 131503 |
Category | Part of a hospital |
Ownership Type | Voluntary Non-profit - Other |
Profit Type | NON-PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 000 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.
According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.3 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.8 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 97.8 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.2 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
Patients who got timely treatment for shortness of breath | 90.2 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.9 | 93.3 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.
According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
› Verified 6 days ago
Home Health Aides | 2 |
Counselors | 2 |
Homemakers | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 6 |
Other Personnel | 3 |
Total Employees | 16 |
---|
News Archive
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.
According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
› Verified 6 days ago
St Luke's Home Care / Hospice Location: 325 West Idaho St, Boise, Idaho, 83702 Phone: (208) 381-2721 |
Saint Alphonsus Home Health & Hospice Location: 9199 West Black Eagle Drive, Boise, Idaho, 83709 Phone: (208) 381-2721 |
First Choice Home Health & Hospice Location: 12400 West Overland Road, Suite 100, Boise, Idaho, 83709 Phone: (208) 381-2721 |
Auburn Crest Hospice Treasure Valley, Llc Location: 3749 N Cloverdale Rd, Boise, Idaho, 83713 Phone: (208) 381-2721 |